Literature DB >> 12543747

Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.

M B Parodi1, S Da Pozzo, G Ravalico.   

Abstract

AIM: To describe the angiographic features after photodynamic therapy (PDT) with verteporfin in choroidal neovascularisation (CNV) associated both with age related macular degeneration (AMD) and pathological myopia (PM).
METHODS: 36 patients affected by subfoveal CNV in AMD and 25 patients with subfoveal CNV in PM underwent an ophthalmological examination including fluorescein angiography (FA) and indocyanine green angiography (ICGA) using the IMAGEnet System. Post-PDT examinations were performed 7, 30, and 90 days later.
RESULTS: The typical angiographic aspect after PDT for AMD related CNV was a round hypofluorescence visible both on FA and on ICGA, which included both CNV and the surrounding tissues and corresponded to the area exposed to laser light. In PM the CNV appeared hypofluorescent during the early phases and gradually became hyperfluorescent during the late phases on FA, whereas on ICGA it was detectable in its whole extension as a hyperfluorescent lesion since the early phases. Differently from AMD, there was no round hypofluorescence surrounding the CNV on FA or on ICGA. Moreover, five patients in the AMD group showed hot spots on ICGA, which spontaneously disappeared during the follow up. Classic and occult components of the AMD related CNV revealed a different angiographic response to PDT, showing with the latter only a partial closure 1 week after PDT followed by a complete reopening at the first month in 100% of cases.
CONCLUSION: The post-PDT hypofluorescence typical of AMD related CNV, especially visible on FA, might be secondary to a combination of choriocapillary occlusion and masking effect due to swelling of retinal pigment epithelium cells. Hot spots in the AMD affected patients could be interpreted as the expression of a non-thermal choroidal vasculitis secondary to PDT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543747      PMCID: PMC1771495          DOI: 10.1136/bjo.87.2.177

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

Review 1.  Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization.

Authors:  U Schmidt-Erfurth
Journal:  Semin Ophthalmol       Date:  1999-03       Impact factor: 1.975

2.  Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.

Authors:  N G Ghazi; N M Jabbour; Z C De La Cruz; W R Green
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Authors: 
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

4.  Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects.

Authors:  F C Delori; D G Goger; C K Dorey
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

6.  Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

Authors:  U E Schnurrbusch; K Welt; L C Horn; P Wiedemann; S Wolf
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

Review 7.  Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.

Authors:  G Lutty; J Grunwald; A B Majji; M Uyama; S Yoneya
Journal:  Mol Vis       Date:  1999-11-03       Impact factor: 2.367

8.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

9.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Authors:  N M Bressler
Journal:  Arch Ophthalmol       Date:  2001-02

10.  Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes.

Authors:  H E Grossniklaus; J D Gass
Journal:  Am J Ophthalmol       Date:  1998-07       Impact factor: 5.258

View more
  9 in total

1.  Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.

Authors:  Paolo Lanzetta; Maurizio Battaglia Parodi; Massimo Ambesi-Impiombato; Giuseppe Ravalico; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

2.  Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy.

Authors:  Suk Ho Byeon; Oh Woong Kwon; Sung Chul Lee; Sung Soo Kim; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2006-03

3.  Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

Authors:  Aya Iriyama; Ryo Obata; Yuji Inoue; Hidenori Takahashi; Yasuhiro Tamaki; Yasuo Yanagi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-06       Impact factor: 3.117

4.  A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration.

Authors:  A M Armbrecht; P A Aspinall; B Dhillon
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

5.  Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.

Authors:  Francesco Bandello; Paolo Lanzetta; Maurizio Battaglia Parodi; Derri Roman-Pognuz; Sandro Saviano; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-18       Impact factor: 3.117

6.  Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area.

Authors:  Nadia Artha Dewi; Mitsuko Yuzawa; Kasumi Tochigi; Akiyuki Kawamura; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

7.  Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial.

Authors:  Niloofar Piri; Hamid Ahmadieh; Ramin Taei; Masoud Soheilian; Reza Karkhaneh; Alireza Lashay; Faegheh Golbafian; Mehdi Yaseri; Mohammad Riazi-Esfahani
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec

8.  Global Tendency and Frontiers of Research on Myopia From 1900 to 2020: A Bibliometrics Analysis.

Authors:  Mengyuan Shan; Yi Dong; Jingyi Chen; Qing Su; Yan Wan
Journal:  Front Public Health       Date:  2022-03-10

9.  OCT Analysis of Retinal Pigment Epithelium in Myopic Choroidal Neovascularization: Correlation Analysis with Different Treatments.

Authors:  Davide Allegrini; Diego Vezzola; Alfredo Borgia; Raffaele Raimondi; Tania Sorrentino; Domenico Tripepi; Elisa Stradiotto; Marco Alì; Giovanni Montesano; Mario R Romano
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.